(Q42454106)

31 October 2017

Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. (English)

1 reference

31 October 2017

0 references

3

1 reference

31 October 2017

2

Werner Kempf

1 reference

31 October 2017

Beate Zagrodnik

1

1 reference

31 October 2017

Beatrix Müller

4

1 reference

31 October 2017

Günter Burg

5

1 reference

31 October 2017

Mirjana Urosevic

6

1 reference

31 October 2017

Reinhard Dummer

7

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

31 October 2017

1 reference

31 October 2017

98

1 reference

31 October 2017

12

1 reference

31 October 2017

2708-2714

1 reference

Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota

31 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Nonmelanoma skin cancer in the United States: incidence.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Sun exposure and skin cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Role of PTCH and p53 genes in early-onset basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Evidence that superficial basal cell carcinoma is monoclonal from analysis of the Ptch1 gene locus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Variations of basal cell carcinomas according to gender, age, location and histopathological subtype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Immunotherapy for nonmelanoma skin cancer: does it have a future?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Radiotherapy for basal cell carcinoma. Local control and cosmetic outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

p53 expression related to the aggressive infiltrative histopathological feature of basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Radiotherapy of skin tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Tissue microarrays: what will they bring to molecular and anatomic pathology?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

The value of typing basal cell carcinomas in predicting recurrence after surgical excision

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Recurrence Rates of Treated Basal Cell Carcinomas: Part 4: X-Ray Therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Radiotherapy for epithelial skin cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Age and site prevalence of histologic subtypes of basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Why classify basal cell carcinomas?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Recurrence rates of treated basal cell carcinomas. Part 1: Overview

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

The development of non-melanocytic skin cancers in people with a history of skin cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

The risk of developing subsequent nonmelanoma skin cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

p53 has a direct apoptogenic role at the mitochondria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11798

7 January 2021

Identifiers

DOI

10.1002/CNCR.11798

1 reference

31 October 2017

1 reference